Insulin degludec has lower rates of nocturnal hypoglycaemia in T1D compared to insulin glargine: Study MD Editorial Team22 Oct 2021 11:00 AM ISTNocturnal hypoglycemia is a serious complication of insulin-treated diabetes, which commonly goes undetected. Patients with T1D have lower...
Dapagliflozin, saxagliptin combo bests glimepiride for controlling blood sugar in diabetes: Study Medha Baranwal30 Sept 2021 12:45 PM ISTUSA: The combo of dapagliflozin+saxagliptin+metformin was associated with better blood sugar control, efficacy, and metabolic benefits than...
SGLT2 inhibitors improve survival over DPP4i in patients with cirrhosis and diabetes: Study Medha Baranwal20 July 2021 11:45 AM ISTPatients with cirrhosis needing additional pharmacotherapy for diabetes beyond metformin experience increased survival with SGLT2i in relation to...
Liraglutide addition to SGLT2 inhibitors intensifies type 2 diabetes treatment: Study Medha Baranwal17 July 2021 12:45 PM ISTDelhi: Liraglutide (1.8 mg) seems to be an effective way to intensify the treatment of type 2 diabetes irrespective of BMI, HbA1c, insulin resistance,...
Bariatric surgery tied to hypoglycemia risk in people without diabetes: Study Medha Baranwal9 Jun 2021 9:30 AM ISTSweden: Bariatric surgery compared to usual care increases the risk of hypoglycemia-related events in patients without diabetes, finds a recent study...
Dapagliflozin Reduces Blood Pressure by Vasodilation, Finds Study MD Bureau25 March 2021 7:58 PM ISTHypertension and type 2 diabetes mellitus (T2DM) are risk factors for cardiovascular disease. Dapagliflozin improves both blood sugar and systolic...
High blood sugar linked to development of dementia, finds study Hina Zahid16 Feb 2021 11:15 AM ISTResearchers have found in a new study that found that people with higher than normal blood sugar levels were 42% more likely to experience cognitive...
SGLT-2 inhibitors significantly lower risk of Atrial Fibrillation: Study Dr Satabdi Saha4 Feb 2021 9:45 AM ISTA recent review published in Diabetes, Obesity & Metabolism and based on a clinical trial suggests that there is a significantly lower risk of...
Ipragliflozin Vs Sitagliptin in T2D with Metformin: A glimpse of NISM study MD Bureau2 Feb 2021 9:46 PM ISTAccording to US and European guidelines, sodium - glucose co - transporter - 2 (SGLT2) inhibitors are considered second‐line drugs after metformin for...
Vitamin D supplementation improves blood sugar after knee surgery in elderly: Study Medha Baranwal20 Jan 2021 11:45 AM ISTSwitzerland: Vitamin D primarily known to promote bone mineralization has also been implicated as having a role in the development of diabetes. In the...
Pioglitazione and bariatric surgery best for NASH treatment: Study Medha Baranwal4 Jan 2021 8:52 PM ISTItaly: Weight loss and hepatic insulin improvement are promising approaches for the treatment of Non‐Alcoholic Steato‐Hepatitis (NASH), suggests a...
SGLT2 inhibitors lowers risk of atrial fibrillation: Review Medha Baranwal4 Jan 2021 6:00 PM ISTUSA: People treated with SGLT2 inhibitors are at significantly lower risk of developing atrial fibrillation (AF), suggests a recent review in the...
